Using educational outreach and a financial incentive to increase general practices’ contribution to chlamydia screening in South-East London 2003–2011 by Sebastian Kalwij et al.
Kalwij et al. BMC Public Health 2012, 12:802
http://www.biomedcentral.com/1471-2458/12/802RESEARCH ARTICLE Open AccessUsing educational outreach and a financial
incentive to increase general practices’
contribution to chlamydia screening in South-East
London 2003–2011
Sebastian Kalwij1,2*, Sarah French2, Rumbi Mugezi3 and Paula Baraitser4,5Abstract
Background: The London Boroughs of Lambeth and Southwark have high levels of sexually transmitted infections
including Chlamydia trachomatis. Modelling studies suggest that reductions in the prevalence of chlamydia
infection will require a high level of population screening coverage and positivity among those screened. General
practice has a potentially important role to play in delivering these levels of coverage since large numbers (up to
60%) of young people visit their general practice every year but previous work suggests that there are barriers to
delivering screening in this setting. The aim of this study was to evaluate an intervention to increase chlamydia
screening in general practice within Primary Care Trusts (PCTs) of Lambeth and Southwark, a strategy combining
financial incentives and supportive practice visits to raise awareness and solve problems.
Methods: Data on age, gender, venue and chlamydia result for tests on under 25 s in Lambeth from 2003–11 was
obtained from the National Chlamydia Screening Programme. We analysed the number and percentage of tests
generated in general practice, and looked at the number of practices screening more than 10% of their practice
cohort of 15–24 year olds, male/female ratio and positivity rates across other screening venues. We also looked at
practices screening less than 10% and studied change over time. We compared data from Lambeth and Southwark
with London and England. We also studied features of the level and type of educational and financial incentive
interventions employed.
Results: Chlamydia tests performed in general practice increased from 23 tests in 2003–4 to 4813 tests in 2010–11
in Lambeth. In Southwark they increased from 5 tests in 2003/04 to 4321 in 2010/11. In 2011, 44.6% of tests came
from GPs in Lambeth and 46% from GP’s in Southwark. In Lambeth 62.7% of practices tested more than 10% of
their cohort and in Southwark this was 55.8%. In Lambeth, postivity rate in 2010/11 was 5.8% in men and 6.0% in
women. In Southwark positivity rate was 3.9% in men and 5.3% in women. In 2003/04 13% tests in general practice
(Lambeth) were from men, this increased to 25% in 2010/11. In Southwark this increased from 20% in 2003/04 to
27.6% in 2010/11. We compared the results with London and national data and showed significant differences
between GP testing in Lambeth and Southwark, and GP testing in London and the rest of England.
(Continued on next page)* Correspondence: sebastiankalwij@mac.com
1Amersham Vale Practice, Waldron Health Centre, London SE14 6LD, United
Kingdom
2NHS Lambeth, 1 Lower Marsh, London SE1 7NT, United Kingdom
Full list of author information is available at the end of the article
© 2012 Kalwij et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Kalwij et al. BMC Public Health 2012, 12:802 Page 2 of 9
http://www.biomedcentral.com/1471-2458/12/802(Continued from previous page)
Conclusions: General practices can be important potential providers of chlamydia tests.
With a combination of sustained support, financial incentives and feedback on performance, general practice may
be able to test a large percentage of 15–24 year olds. General practice is also a potentially important provider of
chlamydia tests to young men.
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testingBackground
The English National Chlamydia Screening Programme
(NCSP) started in 2003. It aims to reduce the prevalence
of chlamydia infection by offering opportunistic testing
to sexually active 15–24 year olds. The London Bor-
oughs of Lambeth & Southwark are deprived, multieth-
nic boroughs with high rates of Chlamydia trachomatis
and other STI’s [1,2]. Chlamydia testing has been offered
in almost 100 different community screening sites ran-
ging from general practice and Community Reproduct-
ive and Sexual Health (CRSH) clinics to schools,
prisons, pharmacies and websites. The Department of
Health set screening targets for the period April 2008-
March 2011: 17% of the 15–24 yrs cohort to be tested in
2008/09, rising to 25% in 2009/10 and 35% in 2010/11
[3]. Modelling studies suggest that reductions in the
prevalence of chlamydia infection will require a level of
population screening coverage and positivity among
those screened that is reflected in the chlamydia diagno-
sis rate of 2400 per 100,000 population set out within
the Public Health Outcomes Framework for England
2013–16 [4,5]. The English Public Health Outcomes
Framework specifies a diagnosis rate of 2400 per
100,000 population [6].
CRSH clinics (specialist sexual health services) are well
placed to offer chlamydia screening but on their own
they cannot reach enough young people in the 15–
24 year old age group to achieve screening coverage
rates sufficient to reduce chlamydia prevalence. In order
to create more capacity for chlamydia screening general
practice was identified as an important provider of tests
[7]. GPs already provide contraception services and see a
large proportion of the population: 75% of young women
and 60% of young men visit their GP every year in the
UK [8]. However as chlamydia screening is not part of
the UK GP contract nor incorporated in the National
Quality and Outcomes Frameworks for primary care it is
difficult to expect GPs to take on this additional work-
load without support. Several studies have shown that
many young people prefer to be seen and treated by
their own GP with whom they are familiar rather than
visiting a specialist sexual health clinic. In contrast to
wide spread belief, young people see this continuity of
care as an advantage [9-11] An added advantage toscreening in general practice is that it can reduce embar-
rassment as the reason for the visit is known only by the
health professional and patient. Young people prefer the
offer of a test within the privacy of a consulting room ra-
ther than the test being initiated by a receptionist, where
patients can be overheard [12].
Several studies have looked at ways to increase screen-
ing for chlamydia in primary care including computer
reminders [13], a small financial incentives [14], work-
shops and regular feedback to clinicians [15-17]. Other
studies have looked at ways to increase healthcare out-
comes in general and the Cochrane library has a large
collection of review articles regarding education out-
reach visits, feedback and financial incentives [18]. A
Cochrane review of target payments to primary care
physicians to increase immunisation rates suggested that
there is insufficient evidence to provide a clear answer
on whether this strategy is effective [19]. However a re-
view of audit and feedback showed that this approach
could be effective when the health professionals are not
performing well to start with, where the person respon-
sible for the audit and feedback is a colleague, where
payments are provided more than once with clear tar-
gets and an action plan included [20-22]. The interven-
tion evaluated here included a financial component,
audit and feedback covering all the elements above,
associated with effective behaviour change. The London
Boroughs of Lambeth and Southwark adopted an ap-
proach to support testing that combined a financial in-
centive to test with sustained, outreach education and




GPs were offered a financial incentive for testing a pro-
portion of their 15–24 year old registered population,
with targets increasing year on year. For example, a
practice screening just 5% of its 15-24 year old cohort
was awarded a small payment of around £100 to £500 at
financial year end, but those reaching higher targets
were awarded greater sums from £850 up to £2600 (de-
pending on practice size). The total sum of money paid
out to practices in Lambeth 2010/11 was £ 27,600 (USD:
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was more generous due to a different payment structure.
Practices were paid per test according to the following
sliding scale: £6 per screen under 10% of sexually active
15–24 year old population, £10 for screening 10% and
£15 for screening 15%. In 2010/11 the money paid to in-
dividual practices varied from £6 to £6300 for the top
screening practice. The total pay out was £ 54,566.00
(USD 85,607, Euros: 69,649). The financial incentive
scheme has been discontinued in Lambeth in October
2011 but is ongoing in Southwark.
Education outreach support
Alongside a full time chlamydia screening co-ordinator,
and input from an additional primary care health promo-
tion facilitator, Lambeth employed a local GP for 8 hours
per month (£5000 per year) from August 2005 onwards
(ongoing at present) to provide an evidence based ap-
proach to supporting screening. This included: practice
specific peer support; workshops on chlamydia screening;
regular feedback on performance. Southwark employed a
chlamydia screening coordinator from 2003, providing a
similar package of support. The coordinator was available
full time and combined her activities with improving
screening in other community venues. All practices in
Lambeth and Southwark were approached (94 in total).
Some practices needed very little support and were
already offering screening to their patients and were only
visited once. Practices with low screening rates were
offered more intense one-hour practice based workshops
to identify and overcome barriers to screening and repeat
visits. The team aimed to generate long term, supportive
relationships with general practices, involving their staff as
a group rather than individual doctors or nurses, as
screening should involve every clinician, especially where
staff turn-over in inner city practices is high. Regular feed-
back to GPs and practice managers on their practice per-
formance was given to each practice, all practices were
audited on management of their positive screens, all prac-
tices were sent newsletters and we shared league tables.
Low screening Lambeth practices (those who screened
less than 10% of their 15–24 year cohort) were identified
at the beginning of each financial year and were
approached during the first half of this year. In the mean-
time we continued providing feedback to higher and mid-
range screening practices in order to keep these practices
motivated. The same strategy was used in Southwark,
which was discussed during joint quarterly meetings. In
addition to this, all practices could approach the team in
case of any problems.
Evaluating the impact of this intervention To evaluate
this intervention we looked retrospectively at all Chla-
mydia tests provided by registered testing sites in Lambethand Southwark between 1st April 2003-31st March 2011.
All chlamydia testing sites have a specific site code so the
origin of each test could be traced back to the testing site.
The National Chlamydia Screening Programme collects
data from each site and these are fed back to the Chla-
mydia Screening Office on a quarterly basis. For each site,
age and sex of the person tested and test result was avail-
able. We analysed these data for young people aged
15–24 years registered with a practice in Lambeth and
Southwark (based on postcode). We excluded tests from
patients who were symptomatic and patients who were
tested in Lambeth or Southwark but were registered else-
where. We compared% of tests in General Practice with
figures from London and England. We included ‘Non
NCSP Non GUM’ data to capture the use of standard
pathology test request forms instead of the NCSP request
form. A typical screening year coincides with the UK tax
year starting in April and ending in March the following
year. During this study we therefore collected data from
1st of April 2003 until 31st of March 2011.
We looked at the percentage of 15–24 year olds
screened rather than the absolute number of patients, as
practice sizes vary and bigger practices have more staff
available to offer tests. National data suggests that young
men are a hard to reach group so we looked at the male/
female ratio of those tested and Lambeth and Southwark
and we compared these with tests done in London and
England. We aimed to increase the number of practices
screening more than 10% of their practice cohort as we
consider this a measure of a systematic approach to
screening. We also looked at individual practices in
Lambeth and Southwark to evaluate our impact on im-
proving low screening practices. We did not have this
level of detail for practices in other PCT’s in London or
England. For this study, ethical approval was not needed
as this was a service evaluation. Data has been anon-
ymised and individual practices cannot be identified.
Results
Lambeth
Year on year there has been an increase in tests across
most of the registered screening sites from 133 in 2003
to 10,803 tests in 2010/11 (Figure 1). This represents
35.6% coverage of the target cohort of 30,345 young
people residing in Lambeth, the highest coverage in
England [3]. In the year 2010/11, 44.6% of all chlamydia
tests came from general practice followed by 36.8% from
the Community Reproductive and Sexual Health clinics,
the first year that more tests were being offered in gen-
eral practice than anywhere else. By 2010/11, 51 out of
the 52 general practices in Lambeth had signed up to
the Screening Programme and 124 visits by the GP
champion had been completed to 52 practices. Of the







2003-4 2004-5 2005-6 2006-7 2007-8 2008-9 2009-10 2010-11























CSHS GP Outreach Internet Pharmacy Other
Figure 1 Chlamydia screening in a selection of community screening sites in Lambeth, London, UK between 2003/04 and 2010/11.
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April 2003-31st March 2011, 20,312 tests (46%) came
from the Community Reproductive and Sexual Health
Clinics, 17,399 tests (39%) from General Practice, 1898
tests (4.3%) came from ‘Outreach youth events’, 1679
tests (3.8%) came from Pharmacies, 908 tests (2%) came
from the Website (www.checkurself.nhs.net), 216 tests
(0.5%) came from midwives and 1772 tests (4%) came
from a wide variety of other screening sites, e.g. prisons
and schools, but each of these sites only contributed
very few tests.
The percentage of men tested in General Practice
increased from 13% (3/23) in 2003/04 to 25% (1191/
4569) in 2010/11 in Lambeth.
With regards to low screening practices there has been
an improvement in practices approached. We show the
results of the 24 low screening practices in Lambeth
(screening < 10% of their target population) in 2008/09
and we compared this with 2010/11 as it takes time for
effect to take place (Figure 2). The average screening
coverage increased from 5.1% to 10.3% 3 years later.
One practice in particular improved from 5.6% to 33%
target cohort coverage. This is the result of at least one
practice visit which included a presentation and an edu-
cational session, a follow up phone call and email com-
munications with the practice lead for chlamydia
screening.Southwark
For Southwark (Figure 3) the results are as follows: by
2010/11 all 43 general practices signed up to the chla-
mydia screening programme (population cohort 15–
24 year olds: 38310) 41783 valid tests from 1st April
2003-31st March 2011, 25.167 tests (60.2%) came from
the Community and Reproductive Sexual Health
Clinics, 13211 tests (31.6%) from General Practice,
1816 tests (4.4%) came from Pharmacies, 916 tests
(2.2%) came from ‘Outreach youth events’, and 673
tests (1.6%) came from the website (www.checkurself.
nhs.net).
The overall chlamydia positivity rate for 2010–11 was
7.8%, 11.1% in CRSH clinics and 5.9% in general prac-
tice. For Southwark the population coverage for 2010/11
was: 24,5% (9401 test, cohort size: 38310).
With regards to low screening practices in Southwark
there has been an improvement in practices approached.
We show the results of the 21 low screening practices
(screening < 10% of their target population) in 2008/09
and we compared this with 2010/11 as it takes time for
effect to take place. The average screening coverage
increased from 5.7% to 12.6% 3 years later. Three prac-
tices screened more than 30% of their target cohort. The
percentage of men tested in General Practice in South-
wark increased from from 20% to 27.6% in the period
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Figure 3 Chlamydia screening in a selection of community screening sites in Southwark, London, UK between 2003/04 and 2010/11.
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Figure 4 Changes in Southwark practices screening< 10% of their target cohort between 2008/09 and 2010/11.
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tests came from General Practice. However there was a
large variation in screening activity amongst the 51 prac-
tices. By 2010/11, 32 practices (62.7%) reached more
than 10% of their target cohort including eight screening
20-30% and four (7.8%) screened more than 30% (Me-
dian: 14% Mean 14%). We saw the same variation in
screens done by GPs in Southwark, where 24 out of 43
practices (55.8%) screened more than 10% of their prac-
tice cohort and four (9.3%) screened more than 30% of
their practice cohort (Median 14% Mean 11%).
Testing for Chlamydia has also increased simultaneously
across all community testing sites in all PCTs in England.
From 2,338 tests in 2003/04 to 221,884 in 2010/11. When
comparing the screening data from Lambeth and South-
wark with London and national levels it shows that the per-
centage of chlamydia tests coming from general practice
are significantly greater in Lambeth and Southwark
(p<0.01) (Figure 5).
In order to intervene effectively to support an increase in
GP screening we identified some common barriers from
the outset: 1. Simple practical barriers such as lack of test
request forms or test kits, or needing to be shown how to
use the computer alerts and templates; 2. A lack of confi-
dence in offering tests in non-sexual health consultations;
3. Some practices did not engage with chlamydia screening
as this was deemed to be outside the realm of primary care
and those GPs sign-posted patients to local specialist clinicsinstead, one Lambeth practice opted out of the Chlamydia
Screening Programme after several years of failing to im-
prove screening uptake.
Discussion
We have shown that it is possible to achieve a high chla-
mydia screening coverage of the 15–24 year population
cohort by involving general practice in addition to the
CRSH. GPs are well placed to treat and manage patients
who test positive for chlamydia as part of a package of
holistic sexual health care.
Thus this study describes a successful implementation
of a combined strategy for chlamydia screening at PCT
level involving 94 practices. It is notable that it appeared
to make no difference whether sustained support for
screening was provided by a fellow general practitioner
or a dedicated chlamydia screening co-ordinator. In both
cases the combination of a financial incentive plus sup-
port seemed to generate similar increases in testing. It is
important to add to this that the Lambeth GP only spent
8 hours per month liaising with practices whilst the
chlamydia screening coordinator was in a full time post.
With regards to the potential influence of financial in-
centive in both PCTs. Lambeth interventions seem to
have achieved greater impact with lower financial outlay.
It is important to note that both PCTs achieved high
community coverage partly because all GP practices ex-
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Figure 5 Comparing the percentage of screens for chlamydia trachomatis in General Practice between Lambeth, Southwark, London
and England, between 2003/04 and 2010/11.
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(2003–2008) efforts were made to get all practices
involved, and in the later stages, efforts were focused on
increasing the percentage of 15–24 year olds screened in
each practice. Most PCTs have not achieved such wide-
spread GP coverage.
Figures 1 and 5 show that the whilst the number of
patients screened for chlamydia in Lambeth increased year
after year (Figure 1), the proportion of tests coming from
general practice has tailed off (Figure 5). This may in part
be related to a simultaneous increase in CRSH capacity.
For example, a Lambeth CRSH clinic was remodelled with
increased access hours in an area where some GPs were
not offering tests routinely. Many GPs sign-post patients to
this new clinic, instead of improving their own services.
Whilst the number of tests increased in General Practice, it
increased even further in the new CRSH.
With regards to variation in screening rates per practice,
in both PCTs, our experience suggests factors explaining
the wide variation in screening may include the motivation
of clinical staff, having a practice lead regularly monitoring
screening activity, responding to computer reminders,
offering open access young people clinics, and having doc-
tors and nurses experienced at sexually transmitted infec-
tion (STI) management. There was no clear link between
smaller practices or larger health centres in offeringscreening for chlamydia, but smaller practices were quicker
to agree to take on screening than larger practices. It is also
suggested that repeat practice feedback saw a bigger in-
crease in testing numbers in the mid-range screening prac-
tices than in those who tested very few patients, but this
observation needs further study, currently underway. Much
of our work has concentrated on improving screening rates
in low screening rates and some success has been observed
(Figures 2 and 4). Meanwhile, some high screening prac-
tices are not able to maintain high levels of screening year
after year. It is important that when focusing on the low
screening practices, not to forget about the high screening
practices.
Limitations
As a service evaluation study, a number of factors oper-
ating alongside those interventions explored could have
had an impact on local screening activity. Early in 2010
a large, national media campaign was launched, focusing
on chlamydia and other STI testing. This awareness rais-
ing campaign is likely to have had a confounding effect
on the number of patients being tested in Lambeth and
Southwark.
We assumed for the purposes of comparative analysis,
that each screen equates to one patient, and that most
patients were only screened once per year. Our service
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number of tests per patient per year.
Both the level of support in both PCTs and the level of
remuneration have not been the same from the start and
therefore this will present as a confounding factor.
Southwark GPs received higher levels of financial in-
centive and this may have motivated some of these more
so than the smaller incentives provided to Lambeth
practices.
It has been observed that whilst the GP only worked
for 8 h per month it was easier and quicker to gain ac-
cess to colleagues. This peer support may have had a dif-
ferent impact on screening levels than the support given
by the chlamydia screening coordinator but who had
more time to support practices. It is important to realise
that the service we evaluated in this paper has not been
set up as a research project, it’s a real time chlamydia
screening programme and was subject to national guide-
lines and targets as set out by the NCSP.
As we chose a multi faced approach it is difficult to
distinguish which part of the intervention may have
had the most impact. We may be able to evaluate this
in more detail in future years. Chlamydia screening will
continue in both PCTs though practices in Lambeth no
longer receive a financial incentive but will get ongoing
support by a GP for 8 h per month. In Southwark how-
ever, the present level of remuneration will continue
but the support from a chlamydia screening coordin-
ator has been discontinued in both PCTs in response
to changes in the national chlamydia screening
strategy.
Over the years many PCTs around London and England
have shown an interest in the Lambeth and Southwark
model, some PCT’s implementing a similar approach. We
are not aware of other PCTs using these interventions
consistently for the same length of time. It is therefore dif-
ficult to compare Lambeth and Southwark with different
PCTs at this level of intervention detail.Conclusions
General practitioners are important potential providers
of chlamydia tests.
With this study we have demonstrated that with a
combination of sustained support, financial incentive
and feedback, general practice may be able to test a
large percentage of the 15–24 year olds in the commu-
nity. General practice is also a potentially important
provider of chlamydia tests to young men – a group
that has been difficult to engage with the national chla-
mydia screening programme. A number of variable
features within practices such as sustained clinician
leadership may also have contributed to the levels of
success alongside the combined intervention approach.Abbreviations
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